SCHEMBL19322288

SCHEMBL19322288

CC(=O)c1ccc2c(c1)C(=O)N(c1ccc(Oc3ccccc3)cc1)C2=O

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PTGES O14684 1/20 0.61
▸ POLB P06746 2/20 0.58
▸ HSD17B10 Q99714 1/20 0.57
▸ BRD4 O60885 1/20 0.56
▸ MET P08581 1/20 0.56
▸ LPAR1 Q92633 1/20 0.56
▸ LPAR5 Q9H1C0 1/20 0.56
▸ LPAR3 Q9UBY5 1/20 0.56
▸ CA1 P00915 4/20 0.55
▸ CA9 Q16790 4/20 0.55
▸ CA2 P00918 2/20 0.55
▸ CA4 P22748 1/20 0.55
▸ MEN1 O00255 3/20 0.54
▸ KMT2A Q03164 3/20 0.54
▸ GFER P55789 1/20 0.54
▸ ALDH1A1 P00352 2/20 0.54
▸ CA12 O43570 2/20 0.52
▸ SCN2A Q99250 1/20 0.52
▸ MAPK1 P28482 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14495068 0.90 MET (0.68) PTGESPOLBBRD4METCA1
SCHEMBL17281694 0.89 PTGES (0.64) PTGESPOLBHSD17B10BRD4LPAR1
SCHEMBL17281691 0.87 PTGES (0.61) PTGESPOLBHSD17B10BRD4LPAR1
SCHEMBL675768 0.86 MEN1 (0.57) PTGESPOLBBRD4METCA1
SCHEMBL12895855 0.85 MET (0.72) POLBHSD17B10METCA1CA9
SCHEMBL9564302 0.85 POLB (0.68) PTGESPOLBHSD17B10BRD4LPAR1
SCHEMBL14016924 0.84 CA9 (0.64) POLBMETCA1CA9CA2
SCHEMBL20081072 0.84 BRD4 (0.60) PTGESPOLBBRD4LPAR1LPAR5
SCHEMBL9803534 0.83 LPAR1 (0.77) PTGESPOLBHSD17B10BRD4LPAR1
SCHEMBL17272758 0.83 BRD4 (0.73) PTGESPOLBBRD4LPAR1LPAR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10450408-B2 Method for making polyarylaliphaticetherketone polymers and copolymers thereof KETONEX LIMITED (GB) 2019-10-22 — — US disclosed
US-20170253696-A1 METHOD FOR MAKING POLYARYLALIPHATICETHERKETONE POLYMERS AND COPOLYMERS THEREOF OXFORD PERFORMANCE MATERIALS, INC 2017-09-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10450408-B2 Method for making polyarylaliphaticetherketone polymers and copolymers thereof DAO, DCXR, LOX PTGES 2171/4885POLB 1166/4885HSD17B10 132/4885
US-20170253696-A1 METHOD FOR MAKING POLYARYLALIPHATICETHERKETONE POLYMERS AND COPOLYMERS THEREOF COASY, FRK, PBK PTGES 2203/4885POLB 813/4885HSD17B10 65/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback